Compare Harley-Davidson Inc (HOG) vs Royalty Pharma plc Class A Ordinary Shares (RPRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Harley-Davidson Inc vs Royalty Pharma plc Class A Ordinary Shares — how do they compare? Harley-Davidson Inc trades at $26.89 (market cap $2.78B), while Royalty Pharma plc Class A Ordinary Shares trades at $56.85 (market cap $25.27B). The key difference: Royalty Pharma plc Class A Ordinary Shares is far larger — about 9.1× Harley-Davidson Inc's market cap, and Harley-Davidson Inc pays the higher dividend (2.8%). Which is the better fit depends on your goals — on Pluang, investors hold Harley-Davidson Inc for 92 Days and Royalty Pharma plc Class A Ordinary Shares for 1 Days on average.
| HOG | RPRX | |
|---|---|---|
Market Cap | $2.78B | $25.27B |
Volume | 2,966,389 | 3,671,183 |
Sector | Consumer Cyclical | Health |
52-Week High | $28.46 | $63.96 |
52-Week Low | $17.19 | $35.44 |
Typical Hold Time | 92 Days | 1 Days |
Enterprise Value | $3.20B | $32.50B |
Dividend Yield | 2.8% | 1.66% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Harley-Davidson (HOG) trades at $26.83, down 0.45% with a bullish technical signal and mixed earnings performance. The stock shows attractive valuation metrics with P/E of 14.86 and P/S of 0.72, while revenue has declined from $5.8B in 2022 to $4.5B in 2025. Recent Q2 2026 earnings beat expectations with $0.75 EPS versus $0.645 expected, though Q1 and Q4 2025 results missed targets. The company maintains a dividend payout with recent $0.1875 declaration.
Outlook remains cautious as revenue declines and margin compression continue, though valuation appears reasonable. Key risks include tariff exposure, competitive pressures, and ongoing revenue contraction. Analyst consensus targets $28.50 with mixed sentiment (27.78% Buy, 61.11% Hold). The stock offers value characteristics but faces fundamental headwinds requiring careful monitoring of turnaround execution.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Harley-Davidson Inc
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →About Royalty Pharma plc Class A Ordinary Shares
Royalty Pharma acquires interests in royalties from biopharmaceutical products. Its model gives it exposure to medicines developed and sold by other life sciences companies.
Read more on RPRX →
